GeneBio Systems
Anti-Cytochrome P450 1A1/CYP1A1 Antibody Picoband®
Anti-Cytochrome P450 1A1/CYP1A1 Antibody Picoband®
SKU:PB9544
Couldn't load pickup availability
Size: 100 μg
Storage: Store at -20℃ for one year from date of receipt. After reconstitution, at 4℃ for one month. It can also be aliquotted and stored frozen at -20℃ for six months. Avoid repeated freeze-thaw cycles.
Form: Lyophilized
Reactivity: Human,Mouse,Rat
Applications: Flow Cytometry,IF,IHC,IHC-F,ICC,WB
Application Details: Western blot, 0.1-0.5μg/ml, Human, Mouse, Rat
Immunohistochemistry (Paraffin-embedded Section), 0.5-1μg/ml, Human, Mouse, Rat
Immunohistochemistry (Frozen Section), 0.5-1μg/ml, Human, Mouse, -
Immunocytochemistry/Immunofluorescence, 2μg/ml, Human
Flow Cytometry (Fixed), 1-3μg/1x106 cells, Human
Gene Name: CYP1A1
Specificity: No cross reactivity with other proteins.
Background: CYP1A1 is involved in phase I xenobiotic and drug metabolism (one substrate of it is theophylline). It is inhibited by fluoroquinolones and macrolides and induced by aromatic hydrocarbons. CYP1A1 is also known as AHH (aryl hydrocarbon hydroxylase). It is involved in the metabolic activation of aromatic hydrocarbons (polycyclic aromatic hydrocarbons, PAH), for example, benzo (a)pyrene (BP), by transforming it to an epoxide. In this reaction, the oxidation of benzo[a]pyrene is catalysed by CYP1A1 to form BP-7,8-epoxide, which can be further oxidized by epoxide hydrolase (EH) to form BP-7,8-dihydrodiol. Finally CYP1A1 catalyses this intermediate to form BP-7,8-dihydrodiol-9,10-epoxide, which is the ultimate carcinogen. However, an in vivo experiment with gene-deficient mice has found that the hydroxylation of benzo (a)pyrene by CYP1A1 can have an overall protective effect on the DNA, rather than contributing to potentially carcinogenic DNA modifications. This effect is likely due to the fact that CYP1A1 is highly active in the intestinal mucosa, and thus inhibits infiltration of ingested benzo (a)pyrene carcinogen into the systemic circulation.
Immunogen: E.coli-derived human CYP1A1 recombinant protein (Position: H183-D320). Human CYP1A1 shares 81.2% amino acid (aa) sequence identity with both mouse and rat CYP1A1.
Clonality: Polyclonal
Contents: Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3.
*This antibody is supplied in a stabilized formulation.
Compatibility with conjugation reactions depends on the chemistry of the conjugation method used.
For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.
Purification: Immunogen affinity purified.
Reconstitution: Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Reference: 1. Beresford AP (1993). CYP1A1: friend or foe?. Drug Metabolism Reviews 25 (4): 503–17. 2. Uno, S (2004). Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation.. Mol Pharmacol 65 (5): 1225–37.
Uniprot ID: P04798
Host: Rabbit
Concentration: Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.
Conjugate: This is the unconjugated antibody. It is also available with 10 conjugation options, including Biotin, Cy3, Fluoro488, Fluoro550, Fluoro594, FITC, HRP, APC, PE, and Fluoro647. A carrier-free (BSA-free) version is also available. Additional charges may apply for some options. Please contact us for a quote
Cross Reactivity: No cross-reactivity with other proteins
Isotype: Rabbit IgG
Phospho_site:
Clone Number:
Observed Molecular Weight: 58 kDa
Calculated Molecular Weight: 58 kDa
Gene ID: 1543
Protein Name: Cytochrome P450 1A1
Gene Full Name: cytochrome P450 family 1 subfamily A member 1
Synonyms: AHH; AHRR; CP11; CYP1; CYP1A1; CYPIA1; Cytochrome P450 1A1; Cytochrome P450 C; Cytochrome P450 form 6; Cytochrome P450 P1; P1 450; P450 C; P450DX
